Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis

Volume: 11, Issue: 8, Pages: 1431 - 1441
Published: Aug 1, 2015
Abstract
Generation 5 (G5) poly(amidoamide) (PAMAM) dendrimers are synthetic polymers that have been broadly applied as drug delivery carriers. Methotrexate (MTX), an anti-folate metabolite, has been successfully used as an anti-inflammatory drug to treat rheumatoid arthritis (RA) in the clinic. In this study, we examine the therapeutic efficacy of G5 PAMAM dendrimer methotrexate conjugates (G5-MTX) that also have folic acid (FA) conjugated to the G5-MTX...
Paper Details
Title
Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis
Published Date
Aug 1, 2015
Volume
11
Issue
8
Pages
1431 - 1441
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.